Correlation of Tim-3 expression with chemokine levels for predicting the prognosis of patients with glioblastoma

Zhu, ZQ; Zhang, XH; Yu, ZP; Zhou, Y; Zhu, SH; Zhang, YH; Lin, XP; Mou, YG; Zhang, J

Zhu, ZQ (corresponding author), Xinjiang Med Univ, Tumor Hosp, Dept Neurosurg, Urumqi, Xinjiang, Peoples R China.; Mou, YG; Zhang, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Neurosurg, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.; Lin, XP (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Nucl Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.

JOURNAL OF NEUROIMMUNOLOGY, 2021; 355 ():

Abstract

Glioblastoma (GBM) immunotherapy, which blocks the checkpoint inhibitor molecule T cell immunoglobulin domain and mucin domain-3 (Tim-3), has potentia......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索